Tadalafil
Product Images NDC 50090-5344

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Tadalafil (NDC 50090-5344). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500905344)

Tadalafil 5 mg label from A-S Medication Solutions showing dosage form as film-coated tablets. The label contains storage instructions to keep the product at 68 to 77 degrees Fahrenheit. The package contains 90 tablets and includes a QR code and barcode. Manufacturer listed as Ajanta Pharma USA Inc.*

FDA Label Image

Figure8 (Tadalafil Fig8)

A line graph showing change from baseline in IPSS Total Score over 12 weeks for Tadalafil 5 mg and placebo. The x-axis represents treatment duration in weeks, and the y-axis shows change from baseline score. Tadalafil shows a greater decrease in score over time compared to placebo, with a significant difference indicated at 12 weeks (p<0.01).*

FDA Label Image

Figure1 (Tadalafil Figure1)

A set of four line charts depicting the differences in blood pressure between Tadalafil and placebo over time. The charts show changes in Standing Systolic BP, Standing Diastolic BP, Supine Systolic BP, and Supine Diastolic BP across a 96-hour period, with data points plotted at intervals including 0, 4, 8, 24, 48, 72, and 96 hours.*

FDA Label Image

Figure2 (Tadalafil Figure2)

Two line graphs depicting the changes in systolic blood pressure over 24 hours after dosing. The top graph shows standing systolic blood pressure, and the bottom shows supine systolic blood pressure. Both compare Tadalafil 20 mg with doxazosin 8 mg versus placebo with doxazosin 8 mg across time post-dose (hours).*

FDA Label Image

Figure3 (Tadalafil Figure3)

A line graph depicting changes in systolic blood pressure (mmHg) over 12 hours after administration of tadalafil or placebo. The graph compares four conditions involving 20 mg tadalafil or placebo and 8 mg doxazosin at 08:00 or 20:00, showing variability in blood pressure response over time.*

FDA Label Image

Figure4 (Tadalafil Figure4)

A line graph depicting plasma tadalafil concentration (µg/L) over time (hours) for three dosing regimens: a single 20-mg dose, a single 5-mg dose, and once-daily 5-mg tadalafil following 5 consecutive days of administration. The graph shows changes in concentration up to 120 hours with error bars indicating variability.*

FDA Label Image

Figure5 (Tadalafil Figure5)

A line graph depicting the change from baseline in IPSS Total Score over a treatment duration of 12 weeks. The graph compares Tadalafil 5 mg, which shows a greater reduction in score over time, against placebo, indicating efficacy differences with statistical significance (p<0.01).*

FDA Label Image

Figure6 (Tadalafil Figure6)

A line graph comparing change from baseline in IPSS total score over 12 weeks of treatment for Tadalafil 5 mg versus placebo. The x-axis shows duration of treatment in weeks, and the y-axis shows change in IPSS score. Tadalafil shows a greater reduction in score compared to placebo, indicated by separate lines with markers and a significance annotation at p<0.01.*

FDA Label Image

Figure7 (Tadalafil Figure7)

A line graph depicting the least-squares mean change from baseline over 26 weeks of therapy comparing Tadalafil/Finasteride and Placebo/Finasteride. The y-axis represents change from baseline, and the x-axis shows weeks of therapy at 0, 4, 12, and 26 weeks. Data points are marked with statistical significance labels (p<0.001 and p<0.05) indicating differences between groups.*

FDA Label Image

Structure (Tadalafil Structure)

Chemical structure of Tadalafil showing its molecular framework with fused rings and functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.